Pleiotropic Effects of Modified Citrus Pectin.

Isaac Eliaz, Avraham Raz

Journal: Nutrients 2020;11(11):2619

PMID: 31683865

Abstract

Modified citrus pectin (MCP) has a low-molecular-weight degree of esterification to allow absorption from the small intestinal epithelium into the circulation. MCP produces pleiotropic effects, including but not limited to its antagonism of galectin-3, which have shown benefit in preclinical and clinical models. Regarding cancer, MCP modulates several rate-limiting steps of the metastatic cascade. MCP can also affect cancer cell resistance to chemotherapy. Regarding fibrotic diseases, MCP modulates many of the steps involved in the pathogenesis of aortic stenosis. MCP also reduces fibrosis to the kidney, liver, and adipose tissue. Other benefits of MCP include detoxification and improved immune function. This review summarizes the pleiotropic effects of MCP.

Address: Amitabha Medical Clinic and Healing Center, 398 Tesconi Ct, Santa Rosa, CA 95401, USA. [email protected].; Departments of Oncology and Pathology, School of Medicine, Wayne State University and Barbara Ann Karmanos Cancer Institute, 4100 John R St, Detroit, MI 48201, USA. [email protected].

DOI: 10.3390/nu11112619

Link outs

Free resources

Full Text Sources:

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Miscellaneous:

https://assays.cancer.gov/CPTAC-327

MeSH Terms: Adipose Tissue, Aortic Valve Stenosis, Blood Proteins, Citrus, Fibrosis, Galectin 3, Galectins, Humans, Kidney Diseases, Liver Cirrhosis, Neoplasms, Pectins, Phytotherapy